Arthur Tzianabos, President and CSO at Tempest Therapeutics, holds 7.98K shares in Q32 Bio (Ticker: QTTB), holds 31.74K shares in Stoke Therapeutics (Ticker: STOK), holds 0.00 shares in AKOUOS (Ticker: AKUS).
What is the percentage of profitable transactions made by Arthur Tzianabos?
The percentage of profitable transactions made by Arthur Tzianabos is 0%.
What is the average return per transaction made by Arthur Tzianabos?
The average return per transaction made by Arthur Tzianabos is -66.80%.
What stocks does Arthur Tzianabos hold?
Arthur Tzianabos holds: TPST, QTTB, STOK, AKUS, BINDQ stocks.
What was Arthur Tzianabos’s latest transaction?
Arthur Tzianabos latest transaction was an Uninformative Buy of $20.09K.
What was Arthur Tzianabos's most profitable transaction?
Arthur Tzianabos’s most profitable transaction was an Informative Buy of TPST stock on April 8, 2015. The return on the trade was -66.40%.
What is Arthur Tzianabos's role in Tempest Therapeutics?
Arthur Tzianabos's role in Tempest Therapeutics is President and CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.